amoxicillin has been researched along with Bowel Diseases, Inflammatory in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Croitoru, K; Goethel, A; Philpott, DJ; Robertson, SJ; Rouquier, S; Streutker, CJ; Turpin, W; Zanello, G | 1 |
| Gadzhieva, MG; Maev, IV | 1 |
2 other study(ies) available for amoxicillin and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Nod2 influences microbial resilience and susceptibility to colitis following antibiotic exposure.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Colitis; Disease Models, Animal; Disease Susceptibility; Fecal Microbiota Transplantation; Gastrointestinal Microbiome; Gene-Environment Interaction; Humans; Inflammatory Bowel Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Nod2 Signaling Adaptor Protein; Risk | 2019 |
[Is anti-helicobacter therapy a rational approach in treatment of erosive and ulcerous lesions of the gastroduodenal mucosa in patients with inflamatory bowel diseases?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Furazolidone; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Inflammatory Bowel Diseases; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Organometallic Compounds; Rabeprazole; Time Factors | 2005 |